Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found four genes that could help diagnose severe alopecia areata early.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

PCOS involves genetic and immune factors, especially T cells, affecting its development.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Immune activities and specific genes are important in male pattern baldness.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Certain genetic markers and low vitamin D3 levels are linked to male pattern baldness.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

Immune changes and specific genes contribute to male hair loss.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Too much zinc can cause hair loss and weaken the immune system.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

New genetic discoveries may lead to better treatments for alopecia areata.

Machine learning can help find new ways to treat alopecia areata.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Key genes and pathways crucial for hair follicle development in cashmere goats were identified, aiding fleece production improvement.

Advanced human skin models improve drug development and could replace animal testing.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

A mouse gene mutation increases the risk of skin cancer.